Skip to content
Tuesday 18 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,728.04
+0.07%
DAX
26,128.36
-0.80%
CAC 40
8,509.36
-0.82%
STOXX 50
6,468.17
-0.95%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Thursday 21 January 2021 11:12 am

London buses converted into temporary ambulances to ease Covid pressure

By: Millie Turner

Add as a preferred source on Google
The makeshift ambulances were coordinated by Go-Ahead, Sprint and Transport for London.

Two London buses have been converted into temporary ambulances to alleviate the pressure of Covid-19 on the NHS across the capital.

Starting the service in the next few days, NHS staff have been prepped and vaccinated to transport up to four patients in the makeshift ambulances which have been stripped of seats and adapted with medical equipment.

Although not exclusively for Covid patients, the buses will have oxygen onboard to provide Covid patients who need it.

The buses have also been fitted with infusion pumps and monitors to ensure patients are stable while being transferred to other hospitals, including the reopened Nightingale field hospital.

Onboard NHS staff will be those from the Covid specific Sprint unit, also known as the Specialist Retrieval and Intensive Care Transfer Service, which was established in March of last year.

The temporary ambulances will also be staffed by St John Ambulance volunteers.

Bus company Go-Ahead loaned the electric vehicles to the NHS and provided four vaccinated drivers for the transfers.

Initially, patients are most likely to be transferred to the Nightingale facility, but the buses also have dedicated stops at King’s College and Guy’s hospitals in south London.

Read more

Ignore Palantir’s political opponents and look at the data: this technology helps patients

NHS logo on a white surface with visible water droplets, blue and white branding

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Transport & Infrastructure

Related Topics

  • Coronavirus
  • London business
  • NHS
  • Transport for London

Trending Articles

  • As it happened: FTSE 100 drops as oil prices rise after Trump makes Hormuz threat

  • Jobless Banquet: Youth unemployment surge ‘sends Neets to KFC’

  • US bond market jitters spark UK economy recession warning

  • Monzo chair makes early exit after boardroom rift

  • Aldi boss wades into supermarket ‘price-gouging’ row

More from Morning Wire

  • Ignore Palantir’s political opponents and look at the data: this technology helps patients

    Opinion
    NHS logo on a white surface with visible water droplets, blue and white branding
  • NHS data counters claims that £330m Palantir deal has led to ‘no improvement’

    Tech
    Brit are seeking financial support from the ‘Bank of Mum and Dad’ to afford private healthcare.
  • Andy Burnham says he will put essential services back under ‘stronger’ public control

    Politics
    Andy Burnham discussing capital gains tax increase during a press conference, highlighting potential economic impacts
  • ‘Good growth in every postcode’? Not in Greater Manchester

    Economics
    Andy Burnham speaking in Manchester, showcasing leadership and urban development initiatives in the city.
  • New Victoria Hospital Goes Live with MEDITECH Expanse to Deliver New Era of Care

    Business Wire
  • Leeds NHS Innovation to Accelerate Global Adoption of AI-enabled Pathology for Cancer Diagnostics Through Epredia Partnership

    Business Wire
  • Cycle Pharmaceuticals Selects Forma Life Sciences to Establish U.S. Commercial Supply for FDA-Approved CAVHANZA™ (nilotinib) Orally Disintegrating Tablets

    Business Wire
  • Nanochon Receives Regulatory Approval from Panamá’s Ministry of Health to Initiate First-in-Human Clinical Study of Chondrograft™

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook